Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1698924

	registered interest
	date	26/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS Greater Manchester: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when she last met with Greater Manchester NHS Board to discuss the statutory commissioning of NICE approved medicines.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	20611
	answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>Ministers have not met with Greater Manchester NHS Board about the statutory commissioning of National Institute for Health and Care Excellence (NICE) recommended medicines. Similarly I am informed that NHS England is not aware of any such discussions.</p><p>The National Health Service in England is legally required to make funding available for treatments recommended in NICE technology appraisal and highly specialised technologies guidance, normally within three months of the publication of final guidance. This requirement is reflected in the NHS Constitution as a right to drugs and treatments that have been recommended by NICE for use in the NHS, if their doctor believes they are clinically appropriate.</p><p>The NHS Standard Contract is mandated by NHS England for use by commissioners for all contracts for healthcare services other than primary care. The 2024/25 standard contract states that, where any service involves or may involve the prescribing of medicines, the provider must ensure that its formulary reflects all relevant positive NICE technology appraisals. NICE’s guideline on developing and updating local formularies states that when a NICE technology appraisal recommends a medicine, it should be adopted into the local formulary automatically if clinically appropriate and relevant to the services provided by the organisation, and that this process should take place within three months.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20612 20613 question first answered 15/04/2024 08:04:14 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4034 label Biography information for Yvonne Fovargue

1698925

	registered interest
	date	26/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS Greater Manchester: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions NHS England have had with Greater Manchester NHS on their statutory responsibilities to commission NICE approved medicines.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	20612
	answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>Ministers have not met with Greater Manchester NHS Board about the statutory commissioning of National Institute for Health and Care Excellence (NICE) recommended medicines. Similarly I am informed that NHS England is not aware of any such discussions.</p><p>The National Health Service in England is legally required to make funding available for treatments recommended in NICE technology appraisal and highly specialised technologies guidance, normally within three months of the publication of final guidance. This requirement is reflected in the NHS Constitution as a right to drugs and treatments that have been recommended by NICE for use in the NHS, if their doctor believes they are clinically appropriate.</p><p>The NHS Standard Contract is mandated by NHS England for use by commissioners for all contracts for healthcare services other than primary care. The 2024/25 standard contract states that, where any service involves or may involve the prescribing of medicines, the provider must ensure that its formulary reflects all relevant positive NICE technology appraisals. NICE’s guideline on developing and updating local formularies states that when a NICE technology appraisal recommends a medicine, it should be adopted into the local formulary automatically if clinically appropriate and relevant to the services provided by the organisation, and that this process should take place within three months.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20611 20613 question first answered 15/04/2024 08:04:14 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4034 label Biography information for Yvonne Fovargue

1698926

	registered interest
	date	26/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments: Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what guidance her Department issues NHS trusts on establishing commissioning structures for Health Technology Assessments; and whether trusts have discretion to adopt different processes.
	tabling member constituency	Makerfield
	tabling member printed	Yvonne Fovargue
	uin	20613
	answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>Ministers have not met with Greater Manchester NHS Board about the statutory commissioning of National Institute for Health and Care Excellence (NICE) recommended medicines. Similarly I am informed that NHS England is not aware of any such discussions.</p><p>The National Health Service in England is legally required to make funding available for treatments recommended in NICE technology appraisal and highly specialised technologies guidance, normally within three months of the publication of final guidance. This requirement is reflected in the NHS Constitution as a right to drugs and treatments that have been recommended by NICE for use in the NHS, if their doctor believes they are clinically appropriate.</p><p>The NHS Standard Contract is mandated by NHS England for use by commissioners for all contracts for healthcare services other than primary care. The 2024/25 standard contract states that, where any service involves or may involve the prescribing of medicines, the provider must ensure that its formulary reflects all relevant positive NICE technology appraisals. NICE’s guideline on developing and updating local formularies states that when a NICE technology appraisal recommends a medicine, it should be adopted into the local formulary automatically if clinically appropriate and relevant to the services provided by the organisation, and that this process should take place within three months.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20611 20612 question first answered 15/04/2024 08:04:14 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4034 label Biography information for Yvonne Fovargue

1692747

	registered interest
	date	29/02/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Equipment: Waste Disposal
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make an assessment of the potential merits of collecting data centrally about levels of (a) reuse and (b) discard of NHS equipment.
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	uin	16318
	answer	answer is ministerial correction date of answer 06/03/2024 answer text <p>The Department published the inaugural Medical Technology Strategy in February 2023, which included a focus on improving resource efficiency. The Department is working with industry, the health and care sector, and academic partners to develop medical technology systems that support reuse, remanufacture, and material recovery, by default. The Department is exploring options for reuse, remanufacture, and material recovery in medical devices, through its Design for Life programme. This includes developing regulatory, commercial, and infrastructure and policy environments that support these aims. As part of the programme, the Department recognises we will need to define future data requirements, and align digital infrastructure to improve the gathering of core data. <br> <br></p><p><br> NHS England has developed a waste planning tool for all National Health Service providers, consistent with the Clinical Waste Strategy, which includes improved waste segregation, minimisation, and increased reuse programmes. This will lead to reductions in the road miles the waste travels, increases in the use of re-usable sharps bins, and furthers plans made towards the achievement of Net Zero Carbon from waste management. <br> <br> NHS England has an ambition to expand existing walking aid refurbishment schemes. Arrangements for the return and reuse of walking aids are managed locally, and a number of NHS trusts already have local return and reuse schemes, with over 200 return sites now featured on the Recycle Now website. Further information is available at the following link:</p><p><a href="https://www.recyclenow.com/recycle-an-item/walking-aids" target="_blank">https://www.recyclenow.com/recycle-an-item/walking-aids</a></p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 06/03/2024 17:42:08 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	3924 label Biography information for Yasmin Qureshi

1698355

	registered interest
	date	25/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Integrated Care Systems: Allergies and Nutrition
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether she has made an assessment of the potential merits of each Integrated care systems having a (a) specialist allergy nurse and (b) dietitian.
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	uin	20254
	answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>The majority of services for people living with allergies are commissioned locally through integrated care boards (ICBs), which are best placed to commission services according to local need. Specialised allergy services are provided for patients with severe and complex allergic conditions, or those who have common allergic conditions for which conventional management has failed and for whom specified specialist treatments are required. In 2023/24, these services are jointly commissioned by NHS England Specialised Commissioning and the ICBs, in line with the published Specialist Allergy Service Specification.</p><p>There is an established Clinical Reference Group (CRG), which is responsible for providing national clinical advice and leadership for specialised immunology and allergy services. The CRG uses its expertise to advise NHS England on the best ways to provide specialised services. This includes developing national standards in the form of service specifications and policies. The CRG commenced a review of the current service specification in May 2023, which is expected to be complete by summer 2024. The outcome of the service specification review will be an updated specification which references up-to-date guidance and takes into account the latest evidence base, to clearly define the standards of care for commissioned specialised services.</p><p>To help promote awareness of allergies, the National Institute for Health and Care Excellence (NICE) has published guidance on a range of allergy conditions, including food allergy in under 19-year-olds, anaphylaxis, and drug allergy. The NICE promotes its guidance via its website, newsletters, and other media.</p><p>To support clinicians in the implementation of clear care pathways, the NICE website has guidance to support diagnosis and treatment of a range of allergy conditions, including how to identify allergies and when to refer to specialist care, and how to ensure allergies are recorded in their medical records.  The NICE website also provides primary care practitioners with access to clinical knowledge summaries outlining the current evidence base and practical guidance on a range of skin conditions.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20255 question first answered 15/04/2024 08:15:46 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	3924 label Biography information for Yasmin Qureshi

1698356

	registered interest
	date	25/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Allergies: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to improve allergy awareness in health care settings.
	tabling member constituency	Bolton South East
	tabling member printed	Yasmin Qureshi
	uin	20255
	answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>The majority of services for people living with allergies are commissioned locally through integrated care boards (ICBs), which are best placed to commission services according to local need. Specialised allergy services are provided for patients with severe and complex allergic conditions, or those who have common allergic conditions for which conventional management has failed and for whom specified specialist treatments are required. In 2023/24, these services are jointly commissioned by NHS England Specialised Commissioning and the ICBs, in line with the published Specialist Allergy Service Specification.</p><p>There is an established Clinical Reference Group (CRG), which is responsible for providing national clinical advice and leadership for specialised immunology and allergy services. The CRG uses its expertise to advise NHS England on the best ways to provide specialised services. This includes developing national standards in the form of service specifications and policies. The CRG commenced a review of the current service specification in May 2023, which is expected to be complete by summer 2024. The outcome of the service specification review will be an updated specification which references up-to-date guidance and takes into account the latest evidence base, to clearly define the standards of care for commissioned specialised services.</p><p>To help promote awareness of allergies, the National Institute for Health and Care Excellence (NICE) has published guidance on a range of allergy conditions, including food allergy in under 19-year-olds, anaphylaxis, and drug allergy. The NICE promotes its guidance via its website, newsletters, and other media.</p><p>To support clinicians in the implementation of clear care pathways, the NICE website has guidance to support diagnosis and treatment of a range of allergy conditions, including how to identify allergies and when to refer to specialist care, and how to ensure allergies are recorded in their medical records.  The NICE website also provides primary care practitioners with access to clinical knowledge summaries outlining the current evidence base and practical guidance on a range of skin conditions.</p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 20254 question first answered 15/04/2024 08:15:46 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	3924 label Biography information for Yasmin Qureshi

1691674

	registered interest
	date	26/02/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Agency Workers
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much NHS England spent on agency staff in each year since 2010.
	tabling member constituency	Ilford North
	tabling member printed	Wes Streeting
	uin	15710
	answer	answer is ministerial correction date of answer 15/04/2024 answer text <p>The first full financial year for which NHS England was in existence, as the NHS Commissioning Board, was 2013/14. NHS England only holds information on agency spend in combination with other commissioning bodies, for instance integrated care boards, formerly known as clinical commissioning groups. The following table shows the total spent on agency staff in NHS England and the commissioning bodies, each year since 2013/14 to 2022/23:<br></p><table><tbody><tr><td><p>Year</p></td><td><p>Spend</p></td></tr><tr><td><p>2013/14</p></td><td><p>£240,000,000</p></td></tr><tr><td><p>2014/15</p></td><td><p>£300,000,000</p></td></tr><tr><td><p>2015/16</p></td><td><p>£310,000,000</p></td></tr><tr><td><p>2016/17</p></td><td><p>£270,000,000</p></td></tr><tr><td><p>2017/18</p></td><td><p>£190,000,000</p></td></tr><tr><td><p>2018/19</p></td><td><p>£160,000,000</p></td></tr><tr><td><p>2019/20</p></td><td><p>£130,000,000</p></td></tr><tr><td><p>2020/21</p></td><td><p>£160,000,000</p></td></tr><tr><td><p>2021/22</p></td><td><p>£160,000,000</p></td></tr><tr><td><p>2022/23</p></td><td><p>£210,000,000</p></td></tr></tbody></table> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 15/04/2024 15:58:15 answering member 4044 label Biography information for Andrew Stephenson previous answer version 21230 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4504 label Biography information for Wes Streeting

1694213

	registered interest
	date	06/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Databases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether she plans to include all patient records held by GPs in the NHS federated data platform.
	tabling member constituency	Ilford North
	tabling member printed	Wes Streeting
	uin	17432
	answer	answer is ministerial correction date of answer 04/04/2024 answer text <p>The Federated Data Platform is a vital upgrade for the National Health Service, allowing it to be much more effective in how it handles its data. It will bring together information about staff, waiting times, equipment and medicines to improve patient outcomes.</p><p> </p><p>Based on agreements between general practices' data controllers and integrated care boards, the Federated Data Platform will have the capability to include elements of local primary care data. This would be limited to the information required to support the provision of care and would only be utilised by local organisations within the local tenants of the Federated Data Platform, and not be shared beyond a local level.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 04/04/2024 09:30:19 answering member 4044 label Biography information for Andrew Stephenson previous answer version 23498 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4504 label Biography information for Wes Streeting

1694508

	registered interest
	date	07/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Databases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many trusts have agreed to join the federated data platform as of 7 March 2024.
	tabling member constituency	Ilford North
	tabling member printed	Wes Streeting
	uin	17632
	answer	answer is ministerial correction date of answer 10/04/2024 answer text <p>The Federated Data Platform is a vital upgrade for the National Health Service, allowing it to be much more effective in how it handles its data, to improve outcomes for patients. It will allow information about staff, waiting times, equipment and medicines to be brought together, to allow better planning of how the NHS uses its resources.</p><p> </p><p>41 trusts have agreed to join the Federated Data Platform, by means of transitioning from their participation in one of the pilot programmes. In parallel, the programme is actively engaging with 29 new trusts, regarding joining the Federated Data Platform in 2024. We are working with regions and local organisations to plan their implementation timeline.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 10/04/2024 12:52:55 answering member 4044 label Biography information for Andrew Stephenson previous answer version 23782 answering member constituency Pendle answering member printed Andrew Stephenson answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4504 label Biography information for Wes Streeting

1694586

	registered interest
	date	07/03/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Department of Health and Social Care: Defamation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to paragraphs 7.16 and 7.17 of the Ministerial Code, on how many occasions have Ministers in her Department informed the Law Officers that they are the defendants in a libel action in (a) their personal capacity, (b) their official position and (c) both since 19 December 2019.
	tabling member constituency	Ilford North
	tabling member printed	Wes Streeting
	uin	17677
	answer	answer is ministerial correction date of answer 14/03/2024 answer text <p>The Department is unable to confirm this information as any advice provided by the Law Officers and the content thereof cannot be disclosed without their authority.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 14/03/2024 16:24:59 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4504 label Biography information for Wes Streeting